A three-year prospective study of specific immunotherapy to inhalant allergens: Evidence of safety and efficacy in 300 children with allergic asthma (vol 7, pg 93, 1997)

被引：0

|

作者：

Cantani, A

Arcese, G

Lucenti, P

Gagliesi, D

Bartolucci, M

机构：

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY | 1998年 / 8卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：68 / 68

页数：1

相关论文

共 9 条

[1] A three-year prospective study of specific immunotherapy to inhalant allergens: Evidence of safety and efficacy in 300 children with allergic asthma
Cantani, A
Arcese, G
Lucenti, P
Gagliesi, D
Bartolucci, M
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 1997, 7 (02) : 90 - 97
[2] Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma
Hui, Yu
Li, Ling
Qian, Jun
Guo, Yun
Zhang, Xilian
Zhang, Xiaojuan
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (03) : 630 - 634
[3] Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study (vol 180, pg 144, 2019)
Cui, L.
Li, J.
Li, Y.
Xia, Z.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 180 (04) : 306 - 306
[4] Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study
Cui, Long
Li, Jun
Li, Yong
Xia, Zhongfang
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 180 (02) : 144 - 149
[5] Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients.(vol 5, pg 2521, 2005)
Vitko, S
Margreiter, R
Weimar, W
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) : 243 - 243
[6] Gender abuse, depressive symptoms, and HIV and other sexually transmitted infections among male-to-female transgender persons: a three-year prospective study (vol 103, pg 300, 2013)
Nuttbrock, L.
Bockting, W.
Rosenblum, A.
Hwahng, S.
Mason, M.
Macri, M.
Becker, J.
AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (02) : E5 - E5
[7] Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial (vol 25, pg 334, 2015)
Karakoc-Aydiner, E.
Eifan, A. O.
Baris, S.
Gunay, E.
Akturk, H.
Akkoc, T.
Bahceciler, N. N.
Barlan, I. B.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2016, 26 (02) : 144 - 144
[8] Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis (vol 122, pg 4047, 2013)
Cervantes, F.
Vannucchi, A. M.
Kiladjian, J-J
BLOOD, 2016, 128 (25) : 3013 - 3013
[9] safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A (vol 93, pg 498, 2016)
Rowe, Patrick
Farley, Tim
Peregoudov, Alexandre
Piaggio, Gilda
Boccard, Simone
Landoulsi, Sihem
Meirik, Olav
CONTRACEPTION, 2016, 94 (03) : 288 - 288